BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9138441)

  • 1. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine.
    Martinez DL; Geyer MA
    Neuropsychopharmacology; 1997 Mar; 16(3):246-55. PubMed ID: 9138441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
    Liechti ME; Geyer MA; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1993; 113(2):284-7. PubMed ID: 7855195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences.
    Farid M; Martinez ZA; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 2000 Dec; 23(6):623-32. PubMed ID: 11063918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
    Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA; McCloskey TC; Kehne JH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):107-16. PubMed ID: 8935805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
    Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
    Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.
    Fletcher PJ; Selhi ZF; Azampanah A; Sills TL
    Neuropsychopharmacology; 2001 Apr; 24(4):399-409. PubMed ID: 11182535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice.
    Dulawa SC; Hen R; Scearce-Levie K; Geyer MA
    Ann N Y Acad Sci; 1998 Dec; 861():79-84. PubMed ID: 9928242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist.
    Feifel D; Melendez G; Shilling PD
    Neuropsychopharmacology; 2003 Apr; 28(4):651-3. PubMed ID: 12655309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.
    Vollenweider FX; Remensberger S; Hell D; Geyer MA
    Psychopharmacology (Berl); 1999 Apr; 143(4):365-72. PubMed ID: 10367553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.
    Halberstadt AL; Buell MR; Price DL; Geyer MA
    Pharmacol Biochem Behav; 2012 Jul; 102(1):88-94. PubMed ID: 22487771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice.
    Yee BK; Chang DL; Feldon J
    Neuropsychopharmacology; 2004 Oct; 29(10):1865-77. PubMed ID: 15127085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA).
    Bubeníková V; Votava M; Horácek J; Pálenícek T
    Behav Pharmacol; 2005 Mar; 16(2):127-30. PubMed ID: 15767849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.
    Kehne JH; Padich RA; McCloskey TC; Taylor VL; Schmidt CJ
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):95-106. PubMed ID: 8935804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors.
    Alsene KM; Carasso BS; Connors EE; Bakshi VP
    Neuropsychopharmacology; 2006 Oct; 31(10):2150-61. PubMed ID: 16407904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.